252 Pre-treatment IL-15 serum levels correlate with the incidence and severity of neurological events following the administration of anti-CD19 CAR-T cells
Madison Davis(Gilead Sciences (Australia)), Davide Bedognetti(Sidra Medical and Research Center), Justin A. Budka(Gilead Sciences (United Kingdom)), Simone Filosto(Gilead Sciences (United States)), Wangshu Zhang
Cited by 1
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Immune Landscape of Cancer
|Immunity|2019|806
An integrated tumor, immune and microbiome atlas of colon cancer
|Nature Medicine|2023|205
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
|Nucleic Acids Research|2014|123